A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Recruiting · NCT07145918 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Recruiting | Phase 2 | 2026-09-15 | NCT07145918 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| California Clinical Trials Medical Group - Parexel /ID# 275751 | Glendale | United States | 1 |
| Cbh Health - Gaithersburg /ID# 272932 | Gaithersburg | United States | 1 |
| CenExel Collaborative Neuroscience Research /ID# 273005 | Los Alamitos | United States | 1 |
| Cenexel Hassman Research Institute (Hri) /ID# 276128 | Marlton | United States | 1 |
| Community Clinical Research - Cross Park Drive /ID# 272977 | Austin | United States | 1 |
| Pillar Clinical Research - Richardson /ID# 275715 | Richardson | United States | 1 |
| Woodland International Research Group /ID# 275747 | Little Rock | United States | 1 |